EU Drug Regulator Backs New Cancer Therapies and Rare Disease Treatments
Europe’s medicines regulator, the European Medicines Agency (EMA), has recommended approval for several new treatments, including three cancer therapies targeting aggressive forms of the disease, alongside other innovative medicines for serious conditions.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
EU drug regulator backs new cancer therapies and rare disease treatments
Europe’s medicines regulator has recommended approval of several new treatments, including three cancer therapies targeting aggressive forms of the disease, following decisions announced last Friday by the European Medicines Agency (EMA). The EMA’s Committee for Medicinal Products for Human Use (CHMP) backed tarlatamab (Imdylltra), a new immunotherapy for extensive-stage small cell lung cancer — one […]
By Marilena Panayi
Read full article →What are the 5 innovative medicines to be launched in Europe
The EMA's Medicines Committee has approved five new medicines for serious diseases with no effective treatments, and recommended extensions of indications for existing medicines The post What are the 5 innovative medicines to be launched in Europe appeared first on ProtoThema English.
By admin
Read full article →Coverage Timeline
Related Stories
Pagasa Warns of Extreme Heat Index Reaching 40°C on Holy Wednesday in Philippines
just now
DILG Warns Public Against Drunk Swimming During Holy Week and Summer
just now
Philippines Joins Global Initiative for School Feeding Programs
just now
PhilHealth to Continue Premium Collection Amid Calls for Pause
just now